This Collection supports and amplifies research related to SDG3, SDG9 and SDG10. This collection highlights research and reviews in the development, optimization, and application of antiviral ...
Estela Giménez, Carlos Solano, José Luis Piñana, Marc Poch, Eva Mateo, Eliseo Albert, Juan Carlos Hernández-Boluda, Paula Amat, María José Remigia, Ariadna ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
Liver stiffness measurement after success with oral antivirals predicts HCC risk, particularly among patients with advanced chronic liver disease.
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
The American Gastroenterology Association (AGA) Institute issued new clinical practice guidelines, providing evidence-based recommendations for managing hepatitis B reactivation (HBVr) in at-risk ...
For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising superpower—the ability to fight off all viruses. Subscribe to our newsletter for the ...
Hosted on MSN
Cidara Therapeutics Granted FDA Breakthrough Therapy Designation For Flu-Preventing Antiviral
Cidara Therapeutics, Inc. (CDTX) on Thursday said that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for its drug CD388 for the prevention of influenza A and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results